The immune system vs. Pseudomonas aeruginosa biofilms
Peter Østrup Jensen
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorMichael Givskov
Department of International Health, Immunology and Microbiology, University of Copenhagen, Denmark
Search for more papers by this authorThomas Bjarnsholt
Department of International Health, Immunology and Microbiology, University of Copenhagen, Denmark
Search for more papers by this authorClaus Moser
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorPeter Østrup Jensen
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorMichael Givskov
Department of International Health, Immunology and Microbiology, University of Copenhagen, Denmark
Search for more papers by this authorThomas Bjarnsholt
Department of International Health, Immunology and Microbiology, University of Copenhagen, Denmark
Search for more papers by this authorClaus Moser
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
Search for more papers by this authorEditor: Gianfranco Donelli
Abstract
Ilya Metchnikoff and Paul Ehrlich were awarded the Nobel price in 1908. Since then, numerous studies have unraveled a multitude of mechanistically different immune responses to intruding microorganisms. However, in the vast majority of these studies, the underlying infectious agents have appeared in the planktonic state. Accordingly, much less is known about the immune responses to the presence of biofilm-based infections (which is probably also due to the relatively short period of time in which the immune response to biofilms has been studied). Nevertheless, more recent in vivo and in vitro studies have revealed both innate as well as adaptive immune responses to biofilms. On the other hand, measures launched by biofilm bacteria to achieve protection against the various immune responses have also been demonstrated. Whether particular immune responses to biofilm infections exist remains to be firmly established. However, because biofilm infections are often persistent (or chronic), an odd situation appears with the simultaneous activation of both arms of the host immune response, neither of which can eliminate the biofilm pathogen, but instead, in synergy, causes collateral tissue damage. Although the present review on the immune system vs. biofilm bacteria is focused on Pseudomonas aeruginosa (mainly because this is the most thoroughly studied), many of the same mechanisms are also seen with biofilm infections generated by other microorganisms.
References
- Alexeyev OA, Marklund I, Shannon B et al. (2007) Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. J Clin Microbiol 45: 3721–3728.
- Alhede M, Bjarnsholt T, Jensen PØ et al. (2009) Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 55: 3500–3508.
- Alvarez ME, Fuxman Bass JI, Geffner JR et al. (2006) Neutrophil signaling pathways activated by bacterial DNA stimulation. J Immunol 177: 4037–4046.
- Babior BM, Kipnes RS & Curnuttte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741–744.
- Balloy V, Verma A, Kuravi S et al. (2007) The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis 196: 289–296.
- Baltimore RS, Christie CD & Smith GJ (1989) Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 140: 1650–1661.
- Banchereau J & Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252.
- Berthold P & Listgarten MA (1986) Distribution of Actinobacillus actinomycetemcomitans in localized juvenile periodontitis plaque: an electron immunocytochemical study. J Periodontal Res 21: 473–485.
- Bjarnsholt T, Jensen PØ, Burmølle M et al. (2005) Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151: 373–383.
- Bjarnsholt T, Kirketerp-Møller K, Jensen PØ et al. (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16: 2–10.
- Bjarnsholt T, Jensen PØ, Fiandaca MJ et al. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulm 44: 547–558.
- Borregaard N & Herlin T (1982) Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 70: 550–557.
- Boyde A & Lester KS (1968) A method of preparing bacterial plaque lining carious cavities for examination by scanning electron microscopy. Arch Oral Biol 13: 1413–1419.
- Brady RA, Leid JG, Cathoun JH et al. (2008) Osteomylitis and the role of biofilms in chronic infection. FEMS Immunol Med Mic 52: 13–22.
- Brazova J, Sediva A, Pospisilo D et al. (2005) Differential cytokine profile in children with cystic fibrosis. Clin Immunol 115: 210–215.
- Carlsson M, Eriksson L, Erwander I et al. (2003) Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin Exp Immunol 21 (suppl 32): S95–S100.
- Cassatella MA, Guasparri I, Ceska M et al. (1993) Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leukocytes. Immunology 78: 177–184.
- Chen DL, Ferkol TW, Mintun MA et al. (2006) Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Resp Crit Care 173: 1363–1369.
- Chhabra SR, Harty C, Hooi DS et al. (2003) Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-l-homoserine lactone as immune modulators. J Med Chem 46: 97–104.
- Chole RA & Faddis BT (2003) Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol 129: 634–636.
- Chun CK, Ozer EA, Welsh MJ, Zabner J & Greenberg EP (2004) Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. P Natl Acad Sci USA 101: 3993–3994.
- Ciofu O, Petersen TD, Jensen P et al. (1999) Avidity of anti-P. aeruginosa antibodies during chronic infection in patients with cystic fibrosis. Thorax 54: 141–144.
- Ciofu O, Bagge N & Høiby N (2002) Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection. APMIS 110: 881–891.
- Costerton W, Veeh R, Shirtliff M et al. (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112: 1466–1477.
- Cryer J, Schipor I, Perloff JR et al. (2004) Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 66: 155–158.
- Davies J, Neth O, Alton E et al. (2000) Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. Lancet 355: 1885–1886.
- Demedts IK, Bracke KR, Maes T et al. (2006) Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Resp Cell Mol 35: 387–393.
- Devey ME, Bleasdale K, Stanley C et al. (1984) Failure of maturation leads to increased susceptibility to immune complex glomerulonephritis. Immunology 52: 377–383.
- Döring G & Høiby N (1983) Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 42: 197–201.
- Döring G, Goldstein W, Röll A et al. (1985) Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect Immun 49: 557–562.
- Downey DG, Bell SC & Elborn JS (2009) Neutrophils in cystic fibrosis. Thorax 64: 81–88.
- Flo TH, Ryan L, Latz E et al. (2002) Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 277: 35489–35495.
- Furseth R (1971) Further observations on the fine structure of orally exposed and carious human dental cementum. Arch Oral Biol 16: 71–85.
- Fuxman Bass JI, Gabelloni ML, Alvarez ME et al. (2008) Characterization of bacterial DNA binding to human neutrophil surface. Lab Invest 88: 926–937.
- Gaggar A, Li Y, Weathington N et al. (2007) Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol-Lung C 293: L96–L104.
- Garrett ES, Perlegas D & Wozniak DJ (1999) Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J Bacteriol 181: 7401–7404.
- Gristina AG, Oga M, Webb LX et al. (1985) Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 228: 990–993.
- Gunther F, Wabnitz GH, Stroh P et al. (2009) Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilm by polymorphonuclear neutrophils (PMN). Mol Immunol 46: 1805–1813.
- Hall-Stoodley L, Hu FZ, Gieseke A et al. (2006) Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296: 202–211.
- Hansen CR, Pressler T, Nielsen KG et al. (2010) Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 9: 51–58.
- Hartl D, Griese M, Kappler M et al. (2006) Pulmonary T(H)2 response in Pseudomonas aeruginosa infected patients with cystic fibrosis. J Allergy Clin Immun 117: 204–211.
- Hoa M, Tomovic S, Nistico L et al. (2009) Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Int J Pediatr Otorhi 9: 1242–1248.
- Hodson JJ (1955) A histopathological study of the bacterial plaque in relation to the destruction of enamel, dentine and bone with special reference to dental caries. P Roy Soc Med 48: 641–652.
- Høiby N, Flensborg EW, Beck B et al. (1977) Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 58: 65–79.
- Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O & Kharazmi A (2001) Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3: 23–35.
- Homøe P, Bjarnsholt T, Wessman M, Sørensen HC & Johansen HK (2009) Morphological evidence of biofilm formation in Greenlanders with chronic suppurative otitis media. Eur Arch Otorhinolaryngol 266: 1533–1538.
- Horikawa M, Tateda K, Tuzuki E et al. (2006) Synthesis of Pseudomonas quorum-sensing autoinducer analogs and structural entities required for induction of apoptosis in macrophages. Bioorg Med Chem Lett 16: 2130–2133.
- Horvat RT & Parmely MJ (1988) Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity. Infect Immun 56: 2925–2932.
- Ito T, Kanzler H, Duramad O et al. (2006) Specialization, kinetics and repertoire of type1 interferon responses by human plasmacytoid predendritic cells. Blood 107: 2423–2431.
- Jahoor A, Patel R, Bryan A et al. (2008) Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer. J Bacteriol 190: 4408–4415.
- James GA, Swogger E, Wolcott R et al. (2008) Biofilms in chronic wounds. Wound Repair Regen 16: 37–44.
- Janeway CA & Travers P (1997) Immunobiology, 3rd edn. Current Biology Ltd, Churchill Livingstone, Garland Publishing Inc., UK/USA.
-
Jarrossay D,
Napolitani G,
Colonna M et al. (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.
Eur J Immunol
31: 3388–3393.
10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- Jensen ET, Kharazmi A, Garred P, Kronborg G, Fomsgaard A, Mollnes TE & Høiby N (1993) Complement activation by Pseudomonas aeruginosa biofilms. Microb Pathog 15: 377–88.
- Jensen PØ, Moser C, Kobayashi O et al. (2004) Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection. Clin Exp Immunol 137: 478–485.
- Jensen PØ, Moser C, Kharazmi A et al. (2006) Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. J Cyst Fibros 5: 145–151.
- Jensen PØ, Bjarnsholt T, Phipps R et al. (2007) Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153: 1329–1338.
- Jesaitis AJ, Franklin MJ, Berglund D et al. (2003) Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 171: 4329–4339.
- Johansen HK, Hougen HP, Rygaard J et al. (1996) Interferon-gamma treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol 103: 212–218.
- Jones AM, Martin L, Bright-Thomas RJ et al. (2003) Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur Respir J 22: 503–506.
- Kadowaki N, Ho S, Antonenko S et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863–869.
- Kania RE, Lamers GE, Vonk MJ et al. (2007) Demonstration of bacterial cells and glycocalyx in biofilms on human tonsils. Arch Otolaryngol 133: 115–121.
- Kaufmann SH (2008) Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol 9: 705–712.
- Kharazmi A (1991) Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol Lett 30: 201–205.
- Kharazmi A & Nielsen H (1991) Inhibition of human monocyte chemotaxis and chemiluminescence by Pseudomonas aeruginosa elastase. APMIS 99: 93–95.
- Kharazmi A, Döring G, Høiby N & Valerius NH (1984) Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro. Infect Immun 43: 161–165.
- Kharazmi A, Rechnitzer C, Schiøtz PO et al. (1987) Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 17: 256–261.
- Kharazmi A, Nielsen H & Bendtzen K (1988) Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF. Immunobiology 177: 363–370.
- Kimbrell DA & Beutler B (2001) The evolution and genetics of innate immunity. Nat Rev Genet 2: 256–267.
- Kirketerp-Møller K, Jensen PØ, Fazli M et al. (2008) Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 46: 2717–2722.
- Kjerulf A, Tvede M, Aldershvile J et al. (1998) Bacterial endocarditis at a tertiary hospital – how do we improve diagnosis and delay of treatment? A retrospective study of 140 patients. Cardiology 89: 79–86.
- Knowles MR & Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571–577.
- Koch C & Høiby N (1993) Pathogenesis of cystic fibrosis. Lancet 341: 1065–1069.
- Koller B, Kappler M, Latzin P et al. (2008) TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 181: 2753–2763.
- Kolpen M, Hansen CR, Bjarnsholt T et al. (2010) Polymorphonuclear leukocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65: 57–62.
- Kristiansen S, Bjarnsholt T, Adeltoft D et al. (2008) The Pseudomonas aeruginosa autoinducer dodecanoyl-homoserine lactone inhibits the putrescine synthesis in human cells. APMIS 116: 361–371.
- Kronborg G, Fomsgaard A, Jensen ET et al. (1993) Induction of oxidative burst response in human neutrophils by immune complexes made in vitro of lipopolysaccharide and hyperimmune serum from chronically infected patients. APMIS 101: 887–894.
- Lam J, Chan R, Lam K et al. (1980) Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28: 546–556.
- Leid JG, Shirtliff ME, Costerton JW et al. (2002) Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 70: 6339–6345.
- Leid JG, Willson CJ, Shirtliff ME et al. (2005) The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 175: 7512–7818.
- Leid JG, Kerr M, Selgado C et al. (2009) Flagellum-mediated biofilm defense mechanisms of Pseudomonas aeruginosa against host-derived lactoferrin. Infect Immun 77: 4559–4566.
- Locksley RM, Heinzel FP, Sadick MH et al. (1987) Murine cutaneous leishmaniasis: susceptibility correlates with different expansion of helper T cell subsets. Ann I Pasteur Paris 138: 744–749.
- Marrie TJ & Costerton JW (1985) Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J Clin Microbiol 22: 924–933.
- Marrie TJ, Nelligan J & Costerton JW (1982) A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66: 1339–1341.
- Mathee K, Ciofu O, Sternberg C et al. (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145: 1349–1357.
- McCormick LL, Karulin AY, Schreiber JR et al. (1997) Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa. J Immunol 158: 3474–3482.
- Meluleni GJ, Grout M, Evans DJ et al. (1995) Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exoploysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol 155: 2029–2038.
- McKeon DJ, Cadwallader KA, Idris S, Cowburn AS, Pasteur MC, Barker H, Haworth CS, Bilton D, Chilvers ER & Condliffe AM (2010) Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation. Eur Respir J 35: 1264–1272.
- Morici LA, Carterson AJ, Wagner VE et al. (2007) Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner. J Bacteriol 189: 7752–7764.
- Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J & Høiby N (1997) Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 105: 838–842.
- Moser C, Kriegbaum NJ, Larsen SO et al. (1998) Antibodies to urinary tract pathogens in patients with spinal cord injuries. Spinal Cord 36: 613–616.
- Moser C, Hougen HP, Song Z, Rygaard J, Kharazmi A & Høiby N (1999) Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 107: 1093–1100.
- Moser C, Kjaergaard S, Pressler T et al. (2000) The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 108: 329–335.
- Moser C, Jensen PO, Kobayashi O, Hougen HP, Song Z, Rygaard J, Kharazmi A & Høiby N (2002) Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response. Clin Exp Immunol 127: 206–213.
- Moser C, Jensen PØ, Pressler T et al. (2005) Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. APMIS 113: 400–409.
- Mosmann TR, Cherwinski H, Bond MW et al. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357.
- Moss RB, Hsu YP & Olds L (2000) Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol 120: 518–525.
- Nathan C (2008) Metchnikoff's legacy in 2008. Nat Immunol 9: 695–698.
- Nathan C, Srimal S, Farber C et al. (1989) Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CDU/CD18 integrins. J Cell Biol 109: 1341–1349.
- Nickel JC & Costerton JW (1993) Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate 23: 107–114.
- Nickel JC, Reid G, Bruce AW et al. (1986) Ultrastructural microbiology of infected urinary stone. Urology 28: 512–515.
- Ohtami S, Kobayashi O & Ohtami H (2001) Analysis of intractable factors in chronic airway infections: role of the autoimmunity induced by BPI-ANCA. J Infect Chemother 7: 228–238.
- Otterlei M, Sundan A, Skjak-Braek G et al. (1993) Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun 61: 1917–1925.
- Parker LC, Whyte MK, Dower SK & Sabroe I (2005) The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 77: 886–892.
- Parks QM, Young RL, Poch KR et al. (2009) Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 58: 492–502.
- Pekovic DD, Adamkiewicz VW, Shapiro A et al. (1987) Identification of bacteria in association with immune components in human carious dentin. J Oral Pathol 16: 223–233.
- Pedersen SS (1992) Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS S28: 1–79.
- Pedersen SS, Kharazmi A, Espersen F et al. (1990) Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun 58: 3363–3368.
- Penna G, Vulcano M, Roncari A et al. (2002) Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 169: 6673–6676.
- Petersen TD, Ciofu O, Pressler T et al. (1996) Quantitative analysis of the IgG and IgG subclasses immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. Thorax 51: 733–738.
- Piccioli D, Tavarini S, Borgogni E et al. (2007) Functional specialization of human circulating CD16 and CD1c myeloid dendritic cell subsets. Blood 109: 5371–5379.
- Pier GB, Coleman F, Grout M et al. (2001) Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun 69: 1895–1901.
- Pressler T, Mansa B, Jensen T et al. (1988) Increased IgG2 and IgG3 concentration is associated with advanced Pseudomonas aeruginosa infection and poor pulmonary function in cystic fibrosis. Acta Paediatr Scand 77: 576–582.
- Pressler T, Pedersen SS, Espersen F et al. (1990) IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Pseudomonas aeruginosa infection investigated by ELISA. Clin Exp Immunol 81: 428–434.
- Pressler T, Karpati F, Granström M et al. (2009) Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 8: 37–42.
- Reid G, Potter P, Delaney G et al. (2000) Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. Int J Antimicrob Ag 13: 305–307.
- Rhoades ER, Archambault AS, Greendyke R et al. (2009) Mycobacterium abscessus glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2. J Immunol 183: 1997–2007.
- Roitt I, Brostoff J & Male D (2006) Immunology, 6th edn. Mosby, UK.
- Ryder C, Byrd M & Wozniak DJ (2007) Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 10: 644–648.
- Sanclement JA, Webster P, Thomas J et al. (2005) Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 115: 578–582.
- Sanderson AR, Leid JG & Hunsaker D (2006) Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 116: 1121–1126.
- Schaudinn C, Gorur A, Keller D et al. (2009) Periodontitis: an archetypical biofilm disease. J Am Dent Assoc 140: 978–986.
- Schiøtz PO, Sørensen H & Høiby M (1979) Activated complement in the sputum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C 87C: 1–5.
- Schnyder-Candrian S, Strieter RM, Kunkel SL et al. (1995) Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes. J Leukocyte Biol 57: 929–935.
- Sedghizadeh PP, Kumar SK & Gorur A (2009) Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 140: 1259–1265.
- Shkreta L, Talbot BG, Diarra MS et al. (2004) Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23: 114–126.
- Simmons WL & Dybvig K (2007) Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect Immun 75: 3696–3699.
- Singh PK, Parsek MR, Greenberg EP et al. (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417: 552–555.
- Skindersoe ME, Zeuthen LH, Brix S et al. (2009) Pseudomonas aeruginosa quorum-sensing signal molecules interfere with dendritic cell-induced T-cell proliferation. FEMS Immunol Med Mic 55: 335–345.
- Stewart JA, Silimperi D, Harris P et al. (1980) Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation 61: 374–380.
- Sun D, Accavitti MA & Bryers JD (2005) Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immun 12: 93–100.
- Tateda K, Ishii Y, Horikawa M et al. (2003) The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect Immun 71: 5785–5793.
- Telford G, Wheeler D, Williams P et al. (1998) The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-l-homoserine lactone has immunomodulatory activity. Infect Immun 66: 36–42.
- Theander TG, Kharazmi A, Pedersen BK et al. (1988) Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun 56: 1673–1677.
- Theilade J (1977) Development of bacterial plaque in the oral cavity. J Clin Periodontol 4: 1–12.
- Van Gennip M, Christensen LD, Alhede M et al. (2009) Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 117: 537–546.
- Vikstrom E, Magnusson KE & Pivoriunas A (2005) The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactone stimulates phagocytic activity in human macrophages through th p38 MAPK pathway. Microbes Infect 7: 1512–1518.
- Vilain S, Cosette P, Hubert M et al. (2004) Comparative proteomic analysis of planktonic and immobilized Pseudomonas aeruginosa cells: a multivariate statistical approach. Anal Biochem 329: 120–130.
- Waar K, Degener JE, Van Luyn MJ et al. (2005) Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J Med Microbiol 54: 937–944.
- Walker TS, Tomlin KL, Worthen GS et al. (2005) Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73: 3693–3701.
- Ware LB & Matthay MA (2000) The acute respiratory distress syndrome. New Engl J Med 342: 1334–1349.
- Whitchurch CB, Tolker-Nielsen T, Ragas PC et al. (2002) Extracellular DNA required for bacterial biofilm formation. Science 295: 1487.
- Williams SC, Patterson EK, Carty NL et al. (2004) Pseudomonas aeruginosa autoinducer enters and functions in mammalian cells. J Bacteriol 186: 2281–2287.
- Wörlitzsch D, Tarran R, Ulrich M et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317–325.
- Wörlitzsch D, Bensel T, Borneff-Lipp M et al. (2007) Pseudomonas aeruginosa and lactate in vitro and in CF sputum. Pediatr Pulm S30: 317.
- Wu L, Estrada O, Zaborina O et al. (2005) Recognition of host immune activation by Pseudomonas aeruginosa. Science 309: 774–777.
- Wysocki AB, Staiano-Coico L & Grinnell F (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101: 164–168.
- Zaborina O, Lepine F, Xiao G et al. (2007) Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathol 3: e35.
- Zautner AE, Krause M, Stropahl G et al. (2010) Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS ONE 5: e9452.
- Zijnge V, Van Leeuwen MBM, Degener JE et al. (2010) Oral biofilm architecture on natural teeth. PLoS ONE 5: e9321.
- Zimmermann S, Wagner C, Muller W et al. (2006) Induction of neutrophil chemotaxis by the quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactone. Infect Immun 74: 5687–5692.
- Yuo A, Kitagawa S, Kasahara T et al. (1991) Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 78: 2708–2714.